Today: October 4, 2015, 7:01 pm

Bulgaria pharmaceuticals market: $1.58bn industry in 2013
Bulgaria Pharmaceuticals and Healthcare Report Q3 2013 - a new market research report on 2014-04-24 08:43:01
According to industry sources, the Bulgarian pharmaceuticals market has reached a standstill.

This is expected to continue throughout 2013, due to the decline in drug prices and the stagnant health insurance fund budget. We expect that the market will post single-digit value increase, on account of inflationary pressures and continued volume demand. Political uncertainty will also add to the negative pressures affecting the wider healthcare market.

Headline Expenditure Projections

- Pharmaceuticals: BGN2.22bn (US$1.46bn) in 2012 to BGN2.31bn (US$1.58bn) in 2013; +3.8% in local currency terms and +8.0% in US dollar terms. Local currency forecast broadly in line with Q213 figures.

- Healthcare: BGN5.60bn (US$3.68bn) in 2012 to BGN5.77bn (US$3.94bn) in 2013; +3.0% in local currency terms and +7.1% in US dollar terms. Local currency forecast broadly in line with Q213 figures, despite slight upward revision of historical figures.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600

# 344 Words
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.